title: Randomized clinical stroke trials in 2003.
abstract: Randomized clinical stroke trials published during 2003 dealt with what impact treatment of stroke risk factors have on reducing future strokes. Treatment of hypertension and hyperlipidemia, and atrial fibrillation with a new anticoagulant, were confirmed to be beneficial. Treatment with female hormones was not beneficial. A potentially important study indicated that donepezil is a useful treatment for dementia in people who have had strokes.
authors.affiliation: Burke Rehabilitation Hospital and Medical Research Institute, Weill Medical College of Cornell University, 785 Mamaroneck Avenue, White Plains, NY 10605, USA. mrabadi@burke.org
authors.forename: Meheroz H
authors.initials: MH
authors.lastname: Rabadi
authors.forename: John
authors.initials: J
authors.lastname: Blass
mesh_terms: D005343:Fibrinolytic Agents / Q000592:standards / Q000627:therapeutic use; D020249:Hormone Replacement Therapy / Q000592:standards; D006801:Humans; D006949:Hyperlipidemias / Q000628:therapy; D006973:Hypertension / Q000628:therapy; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000517:prevention & control / Q000628:therapy*; D013927:Thrombosis / Q000628:therapy
chemical_list: D005343:Fibrinolytic Agents